Methodology
This audit covers 30 standing desk products from 14 brands sold in the United States during Q2 2026 (April through June 2026). Brands selected for inclusion: Uplift Desk, Fully (Jarvis), Vari, FlexiSpot, Branch, Autonomous, IKEA, Steelcase, Herman Miller, Humanscale, Vivo, Mount-It, Apex Desking, and Progressive Desk. Selection criteria:
- Active commercial offering on the brand's public product page during the audit window
- Sit-to-stand height-adjustable desk (full desk or converter), excluding pure desk risers without their own marketing claims
- At least one explicit health, productivity, or ergonomic claim in product copy or feature bullets
Claim collection protocol
For each product, two reviewers independently captured every distinct health, productivity, or ergonomic claim from the brand's product page, the brand's main category landing page, and the first paid advertising placement returned by a search for the product name. Claims were recorded verbatim, then deduplicated to a canonical list. Pricing reflects the base configuration list price in USD on the brand's direct site. Claims that referred only to mechanical specs (height range, motor lift speed, weight capacity) were excluded. Claims that depended on the desk being used a specific way (for example, "if you stand for 4 hours per day") were retained at their as-stated framing.
Evidence-grading rubric
Each unique claim was matched to the strongest available peer-reviewed source. Preference order:
- Cochrane systematic reviews and updates (notably the Cochrane workplace interventions for reducing sitting at work review and its updates)
- PubMed-indexed meta-analyses and systematic reviews
- PubMed-indexed randomized controlled trials
- Occupational epidemiology cohort studies (Stamatakis et al. 2018, Tuchsen et al. 2005)
- Government technical guidance from NIOSH and OSHA
Evidence was assigned a grade using Cochrane GRADE conventions: high (consistent RCT evidence, low risk of bias), moderate (mixed but directionally consistent RCT or systematic review evidence), low (few RCTs, observational evidence, or significant heterogeneity), very low (mechanistic or anecdotal evidence only). For this study, the strongest grade reached for any standing-desk claim is moderate, because the Cochrane review explicitly downgraded for short follow-up windows and small sample sizes.
Verdict scoring rubric
Each claim was scored against its matched evidence as one of four verdicts:
- Supported: claim direction and magnitude match the peer-reviewed evidence base
- Partially supported: direction is correct, but magnitude is overstated, the effect is short-term only, or the claim is context-dependent in a way the marketing copy does not convey
- Unsupported: there is no peer-reviewed evidence base for the claim as marketed
- Contradicted: the best available evidence points the opposite direction
Brand transparency score is a 0-to-100 composite of (a) presence of a citations or evidence section on the product page, (b) accuracy of any cited studies, (c) absence of unsupported superlatives such as cure, eliminate, or guaranteed, and (d) qualified language on contested claims (for example "may reduce" rather than "reduces"). Scoring was blinded to verdict counts to avoid circularity.
The full dataset, including each claim, its category, the matched citation, the evidence grade, and the verdict, is available at data.json under a CC-BY 4.0 license. Context for the broader market is available in DeskDeploy's 2026 remote-work statistics roundup, which sizes the relevant audience of home-office workers buying standing desks.
Finding 1: 12.7% of standing desk health claims are supported by peer-reviewed evidence
Headline: 18 supported, 47 partially supported, 64 unsupported, 13 contradicted (n=142)
Across 142 distinct claims, only 18 are fully supported by peer-reviewed evidence at the moderate or higher grade level, while 64 are unsupported and 13 are directly contradicted by occupational and metabolic studies. The largest bucket, partially supported (47 claims, 33.1%), captures cases where the direction of the effect is correct but the magnitude is overstated or the effect is short-term. The Cochrane workplace interventions review consistently downgrades evidence for sit-stand workstations to moderate or low because of short follow-up periods and high heterogeneity, and that ceiling propagates into this audit.
Finding 2: 22 of 30 products claim weight loss; the underlying calorie differential is roughly 8-9 kcal per hour
Headline: 0 of 22 weight-loss claims fully supported; 4 contradicted
22 of 30 audited products carry a weight-loss or extra-calorie-burn claim in some form, ranging from soft framings ("burns more calories than sitting") to hard quantitative ones ("burns up to 1000 extra calories per week", "burns 30% more calories", "burns up to 50% more calories"). The 2018 meta-analysis by Saeidifard and colleagues in the European Journal of Preventive Cardiology pooled 46 trials and found a standing-vs-sitting energy expenditure differential of roughly 0.15 kcal per minute, or about 8 to 9 kcal per hour. At a generous 4-hour daily standing dose, that is roughly 32 kcal per day, less than one tablespoon of olive oil and well below the threshold for clinically meaningful weight loss. None of the 22 weight-loss claims at their as-marketed magnitude are supported; 4 are directly contradicted by the magnitude in Saeidifard.
Finding 3: Lower-back-pain is the best-supported claim category
Headline: 8 supported, 14 partial, 5 unsupported, 0 contradicted (n=27)
Lower-back-pain reduction is the most defensible claim a standing desk vendor can make. Of 27 back-pain claims, 8 (29.6%) are fully supported and 14 (51.9%) are partially supported, with no contradictions. The supporting evidence is the Cochrane review of workplace interventions for reducing sitting at work, which finds moderate-grade evidence that sit-stand desks reduce reported low back pain in office workers in the short term. The Cochrane review caveats apply: most trials are short (under 12 months), sample sizes are small, and the back-pain benefit appears to be driven by sit-stand alternation rather than standing alone. Brands that frame the benefit as "supports posture variation that reduces back pain" (Steelcase, Herman Miller, Branch, IKEA) score supported; brands that frame it as "eliminates back pain" or "cures sciatica" would be unsupported, although none in this audit cross that line.
Finding 4: Longevity claims are dominated by contradictions
Headline: 0 supported, 1 partial, 4 unsupported, 6 contradicted (n=11)
Longevity claims are the worst-performing category in the audit. Of 11 longevity or all-cause-mortality claims, 0 are supported, 1 is partial (Branch's narrowly-framed "reduces sedentary risk factors"), and 6 are directly contradicted. The contradiction comes from Stamatakis et al. 2018 in the American Journal of Epidemiology, a 7,000-plus-person Canadian cohort that found prolonged occupational standing was associated with higher cardiovascular mortality risk than sitting, with hazard ratios in the 1.32 to 2.0 range depending on standing dose. No randomized controlled trial has shown a standing desk reduces all-cause mortality or extends life. Marketing copy that claims a desk "helps you live longer" is contradicted by the strongest available occupational epidemiology, not merely unsupported.
Finding 5: Circulation claims point the wrong direction
Headline: 38.5% of circulation claims are directly contradicted
Circulation is a category where brand marketing copy actively misleads. Of 13 circulation claims, 0 are supported, 2 are partial, 6 are unsupported, and 5 (38.5%) are directly contradicted. The contradiction stems from established occupational epidemiology: prolonged standing is a recognized risk factor for varicose veins and lower-limb venous insufficiency. Tuchsen et al. 2005 in Occupational and Environmental Medicine found a roughly 2x increased varicose-vein hospitalization rate in jobs with prolonged standing exposure. The 2018 review by Coenen and colleagues in the Scandinavian Journal of Work, Environment and Health reached similar conclusions. Brands claiming a standing desk "improves circulation" are inverting the dose-response relationship from the occupational health literature, where standing all day is the exposure and varicose veins are the outcome.
Finding 6: Brand transparency is low across the category
Headline: Mean transparency score 32 of 100; range 8 (Mount-It) to 72 (Herman Miller)
No brand in the audit clears 75 of 100 on transparency, and the mean is 32 of 100. The transparency score rewards brands that cite primary literature on product pages, frame claims with hedged language (may, supports, associated with), and avoid superlatives such as cure, eliminate, or guaranteed. The leaders are the contract-furniture brands: Herman Miller (72), Steelcase (70), and IKEA (65). The trailers are direct-to-consumer Amazon-channel brands: Mount-It (8), Progressive Desk (10), and Vivo (12), which lean on bullet-list health claims with no qualifying language and no citations. The pattern matches what FTC truth-in-advertising staff would expect: brands selling into corporate procurement face institutional purchasers who scrutinize claims, while brands selling into Amazon's consumer surface face less downstream review.
Finding 7: Productivity claims are unsupported as a category
Headline: 8.3% of productivity claims supported; objective measures show null effects
Productivity claims appear on 24 of 30 products but only 2 (8.3%) are supported. The 2019 systematic review by Chambers and colleagues in Applied Ergonomics pooled the available trial evidence and found that self-reported energy and engagement rise modestly in some sit-stand desk studies, but objective productivity outcomes (call center throughput, typing speed, error rates, knowledge-work task completion) show null or slightly negative effects. Brands claiming "boosts productivity by 46%" or similar are typically referring to a single non-randomized 2016 Texas A&M call-center observational study (Garrett et al.) that has not replicated and that does not isolate the desk from other workstation changes. Productivity is the second-most-marketed claim category and the second-worst-supported, after longevity.
Finding 8: Higher-priced products carry slightly more defensible claims
Headline: Products above $1,000 average 25% supported; products under $400 average 7% supported
Among the 30 products, the seven priced above $1,000 (Steelcase, Herman Miller, Humanscale, Uplift V2 4-Leg) average 25% supported claims. The five priced under $400 (Vivo, Mount-It, Apex Desking, FlexiSpot Comhar, Autonomous Core) average 7% supported claims and 18% contradicted claims. The mechanism is not that more expensive desks work better physiologically, since the underlying ergonomic and metabolic effects do not depend on price. The mechanism is brand category: contract-furniture brands (Herman Miller, Steelcase, Humanscale) cite the Cochrane review by name on their product pages, hedge with "may" and "supports", and avoid quantitative superlatives. Their copy is written for purchasing managers and ergonomists, not Amazon shoppers.
Finding 9: Blood-glucose claims are the most reasonable when narrowly framed
Headline: 71.5% of blood-glucose claims supported or partially supported; 0% contradicted
Post-meal blood-glucose claims hold up better than any category except back pain: 28.6% supported, 42.9% partially supported, 28.6% unsupported, 0% contradicted. The supporting evidence is the 2014 Buckley et al. trial in Occupational and Environmental Medicine, which found postprandial glucose excursions reduced by roughly 43% when participants stood for 185 minutes after lunch versus sitting. Effect sizes in subsequent trials cluster in the 5 to 15 percent range. Brands that frame the claim narrowly ("supports healthier blood sugar after meals", "may help post-meal glucose regulation") score supported. Brands that frame it broadly as "diabetes prevention" or "blood sugar regulation" without the post-meal context score unsupported, because no RCT has linked standing desk use to incident type 2 diabetes prevention.
Finding 10: Aggregate worst-offender claim is "improves circulation"
Headline: "Improves circulation" appears on 8 products; 5 contradicted, 0 supported
Across the dataset, the single most-frequently-misleading claim is "improves circulation" (or close paraphrase). It appears on 8 of 30 products: Uplift V2 Standard, Fully Jarvis Bamboo, Vari, Vari Essential, FlexiSpot E7 Pro, Autonomous SmartDesk Core, Vivo, and Progressive Desk. Of those 8 instances, 5 are directly contradicted and the remaining 3 are unsupported. None reach partial. This is the cleanest example of brand marketing inverting the occupational epidemiology, because prolonged standing is the classical occupational exposure for varicose vein development, not a treatment for circulation problems. A consumer-protection complaint focused on circulation claims would target the densest cluster of contradicted marketing copy in the audit.
Limitations
Five limitations apply. First, claim collection captured marketing copy at a single point in time during Q2 2026; brands routinely refresh product pages and may have moderated claims since the audit window. Second, evidence-grade assignment depends on the strongest published study at the time of writing; future Cochrane updates (the Cochrane workplace interventions review is updated on a roughly 4-year cycle) may shift grades. Third, the sample of 30 products covers the largest direct-to-consumer and contract brands but excludes regional and white-label brands. Fourth, brand transparency scoring is partly subjective despite blinding; we publish the rubric in the methodology so readers can re-score. Fifth, this audit evaluates claim accuracy, not ergonomic performance or build quality; a brand can score low on transparency and still produce a well-engineered desk. The companion 2026 remote work statistics study contextualizes the audience that buys these desks but does not score the desks themselves.
Embed and reuse
Press kit and downloads
Full press kit at /press/, machine-readable per-claim dataset at data.json. Media inquiries via the contact on the press page. Related: 2026 Remote Work Statistics.